Peer Exchange

Infectious diseases physicians and pharmacists review the 2026 IDSA guidance on antimicrobial-resistant gram-negative infections, from the rise of NDM carbapenemases and mechanism-directed therapy to DTR Pseudomonas, CRAB, and Stenotrophomonas, and share practical strategies for diagnostics, renal dosing, formulary access, laboratory readiness, and stewardship

Panel of Flu Experts

Importance of patient education and early testing to differentiate between influenza and COVID-19.